Case-based evidence links increased SARS-CoV-2 diversity to impaired IFN-I response in severe COVID-19
Authors:
- David BussyDBDavid Bussy
- Kylian TrepatKTKylian Trepat
- Hadrien RegueHRHadrien Regue
- Valérie CheynetVCValérie Cheynet
- Laurence GenerenazLGLaurence Generenaz
- Louis ChauvelotLCLouis Chauvelot
- Jean-Christophe RichardJRJean-Christophe Richard
- Mehdi MezidiMMMehdi Mezidi
- Hodane YonisHYHodane Yonis
- Laurent BitkerLBLaurent Bitker
- Guillaume DenielGDGuillaume Deniel
- Ines NoirotINInes Noirot
Open Access
- 24 July 2025
- journal article
- Published by Rockefeller University Press in Journal of Human Immunity
- Vol. 1 (3)
Abstract
Severe COVID-19 with neutralizing anti–type I interferon autoantibodies correlates with high intra-host SARS-CoV-2 diversity. Findings suggest that impaired interferon-mediated viral control may facilitate the emergence of viral variants within individual patients during prolonged infection.Keywords
Funding Information
- Agence Nationale de la Recherche (ANR-21-RHUS-08)
- Agence Nationale de la Recherche (ANR-23-CHIN-0001)
This publication has 5 references indexed in Scilit:
- Within-host genetic diversity of SARS-CoV-2 lineages in unvaccinated and vaccinated individualsNature Communications, 2023
- Detection and prevalence of SARS-CoV-2 co-infections during the Omicron variant circulation in FranceNature Communications, 2022
- Remdesivir-induced emergence of SARS-CoV2 variants in patients with prolonged infectionCell Reports Medicine, 2022
- Human genetic and immunological determinants of critical COVID-19 pneumoniaNature, 2022
- Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNsJournal of Experimental Medicine, 2021